Biocartis Group N.V.
OTC: BIOGF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Roger Moody
- Employees
- 526
- Headquarters
- Mechelen, Belgium
- IPO year
- 2021
- Market cap
- $65.4M
- Website
- https://www.biocartis.com
Loading BIOGF…
Loading profile data…Frequently asked questions about BIOGF
What does Biocartis Group N.V. (BIOGF) do?
Biocartis Group N.V. is a molecular diagnostics firm dedicated to advancing clinical practice through innovative diagnostic solutions. These offerings aim to benefit patients, clinicians, healthcare payers, and the wider healthcare industry, with a particular emphasis on the field of oncology. Central to their product portfolio is the proprietar...
Where does BIOGF trade?
Biocartis Group N.V. (BIOGF) trades on the Other OTC.
What sector is BIOGF in?
Biocartis Group N.V. (BIOGF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Biocartis Group N.V.?
Roger Moody is the chief executive officer of Biocartis Group N.V. (BIOGF).
Where is Biocartis Group N.V. headquartered?
Biocartis Group N.V. is headquartered in Belgium.
Does BIOGF pay a dividend?
Biocartis Group N.V. (BIOGF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIOGF go public?
Biocartis Group N.V. (BIOGF) completed its initial public offering in 2021.